Annals of Oncology, 0923-7534

Journal

1 - 41 out of 41Page size: 50

Publications

  1. 2019
  2. Published

    Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, Nov 2019, In: Annals of Oncology. 30, 11, p. 1776-1783 8 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: An international rare cancers initiative (IRCI) ocular melanoma study

    Leila Khoja & 6 others, , Aug 2019, In: Annals of Oncology. 30, 8, p. 1370-1380 11 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Evolutionary dynamics of residual disease in human glioblastoma

    Colin Watts, Mar 2019, In: Annals of Oncology. 30, 3, p. 456-463 8 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2017
  6. Published

    Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

    Leila Khoja, 31 Oct 2017, In: Annals of Oncology. 28, 10, p. 2377-2385 9 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

    Daniel Rea & 1 others, , 27 Apr 2017, In: Annals of Oncology.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: Analysis from 2530 patients in randomised clinical trials

    Gary Middleton, Mar 2017, In: Annals of Oncology. 28, 3, p. 562-568

    Research output: Contribution to journal › Article › peer-review

  9. 2016
  10. Published

    Consensus on precision medicine for metastatic cancers: a report from the MAP conference

    Gary Middleton, Aug 2016, In: Annals of Oncology. 27, 8, p. 1443-1448 6 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975

    Tom Sorahan, 1 May 2016, In: Annals of Oncology. 27, p. 933-941 9 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2015
  13. Published

    The National Lung Matrix Trial : translating the biology of stratification in advanced non-small-cell lung cancer

    Gary Middleton & Lucinda Billingham, 12 Dec 2015, In: Annals of Oncology. 26, 12, p. 2464-2469

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study

    Cristina Ronchi & 7 others, , Oct 2015, In: Annals of Oncology. 26, 10, p. 2119-2125 7 p.

    Research output: Contribution to journal › Article › peer-review

  15. Published

    Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

    Gary Middleton, David Richards, Jan 2015, In: Annals of Oncology. 26, 1, p. 149-56 8 p.

    Research output: Contribution to journal › Article › peer-review

  16. 2014
  17. Published

    Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study

    Neil Steven & 1 others, , Mar 2014, In: Annals of Oncology. 25, 3, p. 700-706 7 p., mdt580.

    Research output: Contribution to journal › Article › peer-review

  18. 2013
  19. Published

    A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

    Rich Fox, 24 Oct 2013, Annals of Oncology, 24, 10, p. 2565 2570 p.

    Research output: Contribution to specialist publication › Article

  20. Published

    Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report

    Gary Middleton & 2 others, , 1 Mar 2013, In: Annals of Oncology. 24, 3, p. 702-709 8 p.

    Research output: Contribution to journal › Article › peer-review

  21. 2011
  22. Published

    Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and haematologists

    Hisham Mehanna, May 2011, In: Annals of Oncology. 22, 5, p. 1209-14 6 p.

    Research output: Contribution to journal › Article › peer-review

  23. 2010
  24. Published

    Management of febrile neutropenia: ESMO Clinical Practice Guidelines.

    Igor Novitzky Basso, Martin Gill, 1 May 2010, In: Annals of Oncology. 21 Suppl 5, p. v252-6

    Research output: Contribution to journal › Article

  25. 2008
  26. Published

    Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer

    Sylvie Freeman, 22 Jul 2008, In: Annals of Oncology. 20, 1, p. 34-40 7 p.

    Research output: Contribution to journal › Article

  27. 2007
  28. Published

    Questioning specialists’ attitudes to breast cancer follow-up in primary care

    Sarah Bathers, 1 Sep 2007, In: Annals of Oncology. 18, 9, p. 1467-1476 10 p.

    Research output: Contribution to journal › Article

  29. 2006
  30. Published

    A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity

    Philip Johnson, 6 Oct 2006, In: Annals of Oncology. 18, 4, p. 768-774 7 p.

    Research output: Contribution to journal › Article

  31. Published

    Targeting angiogenesis with monoclonal antibodies.

    Roy Bicknell, 1 Sep 2006, In: Annals of Oncology. 17 Suppl 10, p. x76-8

    Research output: Contribution to journal › Article

  32. Published

    Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma

    Philip Johnson, 2 Jun 2006, In: Annals of Oncology. 17, p. 1083-1089 7 p.

    Research output: Contribution to journal › Article

  33. Published

    Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer

    Richard Gray, Christopher McConkey, 1 Mar 2006, In: Annals of Oncology. 17, p. 401-408 8 p.

    Research output: Contribution to journal › Article

  34. 2005
  35. Published

    Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/ cyclophosphamide (AC) in operable breast cancer: Analysis of response and tolerability in a randomised phase III trial (TOPIC 2)

    & 22 others, , Timothy Howell & Daniel Rea, 1 Sep 2005, In: Annals of Oncology. 16, 9, p. 1435-1441 7 p.

    Research output: Contribution to journal › Article › peer-review

  36. Published

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first line therapy for advanced colorectal cancer

    Daniel Rea, Neil Steven, 25 May 2005, In: Annals of Oncology. 16, 7, p. 1123-1132 10 p.

    Research output: Contribution to journal › Article

  37. 2004
  38. Published

    Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy

    Philip Johnson, 1 Jan 2004, In: Annals of Oncology. 15, p. 1661-1666 6 p.

    Research output: Contribution to journal › Article

  39. 2003
  40. Published

    Anything in modulation?

    Richard Gray, Robert Hills, 1 Sep 2003, In: Annals of Oncology. 14, 9, p. 1338-1339 2 p.

    Research output: Contribution to journal › Editorial

  41. Published

    Adjuvant therapy in pancreatic cancer: Historical and current perspectives

    Deborah Stocken, Janet Dunn, 1 May 2003, In: Annals of Oncology. 14, 5, p. 675-692 18 p.

    Research output: Contribution to journal › Article

  42. Published

    A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma (NHL)

    Burton Marshall & Lynn Jones, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 258-267 10 p.

    Research output: Contribution to journal › Article

  43. Published

    The effect of Epstein-Barr virus status on survival in age and sex defined subgroups of patients with advanced Hodgkin's disease

    Lucinda Billingham, Joanne Gough, Lawrence Young & Paul Murray, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 282-290 9 p.

    Research output: Contribution to journal › Article

  44. Published

    Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study

    1 Jan 2003, In: Annals of Oncology. 14, 1, p. 110-115 6 p.

    Research output: Contribution to journal › Article

  45. 2002
  46. Published

    Palliative care in hospital, hospice, at home: results from a systematic review

    31 Dec 2002, In: Annals of Oncology. 13, p. 257-264 8 p.

    Research output: Contribution to journal › Article

  47. Published

    Adjuvant interferon for melanoma

    Keith Wheatley & Natalie Rowland, 1 Jan 2002, In: Annals of Oncology. 13, p. 1319-1320 2 p.

    Research output: Contribution to journal › Letter

  48. Published

    Paediatric lymphoproliferative disease: UKCCSG 9494 study of prognostic variables and outcome

    1 Jan 2002, In: Annals of Oncology. 13, p. 13 1 p.

    Research output: Contribution to journal › Article

  49. 2001
  50. Published

    A Phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer

    Syed Hussain, Deborah Stocken & Nicholas James, 1 Jan 2001, In: Annals of Oncology. 12, 7, p. 929-935 7 p.

    Research output: Contribution to journal › Article

  51. Published

    Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy

    Richard Gray, Christopher McConkey, 1 Jan 2001, In: Annals of Oncology. 12, p. 685-691 7 p.

    Research output: Contribution to journal › Article

  52. Published

    Hepatocellular carcinoma

    Syed Hussain, David Ferry, Nicholas James & David Kerr, 1 Jan 2001, In: Annals of Oncology. 12, p. 161-172 12 p.

    Research output: Contribution to journal › Article

  53. Published

    Preclinical and clinical study of QC12, a water soluble prodrug of quercetin

    Paul Mulholland, David Ferry, Syed Hussain, Annie Young, Leonard Seymour & David Kerr, 1 Jan 2001, In: Annals of Oncology. 12, p. 245-248 4 p.

    Research output: Contribution to journal › Article

  54. Published

    The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

    Lucinda Billingham, 1 Jan 2001, In: Annals of Oncology. 12, 12, p. 1671-1675 5 p.

    Research output: Contribution to journal › Article

  55. Published

    The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy

    Simon Grumett, Rachel Midgley, Paul Mulholland, Shibani Nicum & David Kerr, 1 Jan 2001, In: Annals of Oncology. 12, p. 575 1 p.

    Research output: Contribution to journal › Article

  56. Published

    Two cultures or two faces?

    David Kerr, 1 Jan 2001, In: Annals of Oncology. 12, p. 7-8 2 p.

    Research output: Contribution to journal › Article

  57. 2000
  58. Published

    Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer

    Christopher Poole, David Luesley, 1 Dec 2000, In: Annals of Oncology. 11, 12, p. 1603-1608 6 p.

    Research output: Contribution to journal › Article